Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker
- PMID: 22566498
- PMCID: PMC3530397
- DOI: 10.1161/HYP.0b013e31825b30f8
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker
Abstract
To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms identified by genome-wide association analysis of the response to candesartan were validated by opposite direction associations with the response to a thiazide diuretic, hydrochlorothiazide. We sampled 198 white and 193 blacks with primary hypertension from opposite tertiles of the race-sex-specific distributions of age-adjusted diastolic blood pressure response to candesartan. There were 285 polymorphisms associated with the response to candesartan at P<10(-4) in whites. A total of 273 of the 285 polymorphisms, which were available for analysis in a separate sample of 196 whites, validated for opposite direction associations with the response to hydrochlorothiazide (Fisher χ(2) 1-sided P=0.02). Among the 273 polymorphisms, those in the chromosome 11q21 region were the most significantly associated with response to candesartan in whites (eg, rs11020821 near FUT4, P=8.98 × 10(-7)), had the strongest opposite direction associations with response to hydrochlorothiazide (eg, rs3758785 in GPR83, P=7.10 × 10(-3)), and had the same direction associations with response to candesartan in the 193 blacks (eg, rs16924603 near FUT4, P=1.52 × 10(-2)). Also notable among the 273 polymorphisms was rs11649420 on chromosome 16 in the amiloride-sensitive sodium channel subunit SCNN1G involved in mediating renal sodium reabsorption and maintaining blood pressure when the renin-angiotensin system is inhibited by candesartan. These results support the use of genomewide association analyses to identify novel genes predictive of opposite direction associations with blood pressure responses to inhibitors of the renin-angiotensin and renal sodium transport systems.
Figures
Comment in
-
Pharmacogenetics of antihypertensive response.Hypertension. 2012 Jun;59(6):1094-6. doi: 10.1161/HYPERTENSIONAHA.112.192559. Epub 2012 May 7. Hypertension. 2012. PMID: 22566497 No abstract available.
-
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.Hypertension. 2013 Jan;61(1):e5. doi: 10.1161/HYPERTENSIONAHA.112.201426. Epub 2012 Nov 12. Hypertension. 2013. PMID: 23150516 No abstract available.
References
-
- Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of veterans affairs cooperative study group on antihypertensive agents. JAMA. 1998;280:1168–1172. - PubMed
-
- Turner ST, Schwartz GL, Chapman AB, Beitelshees AL, Gums JG, Cooper-DeHoff RM, Boerwinkle E, Johnson JA, Bailey KR. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens. 2010;23:1014–1022. - PMC - PubMed
-
- Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension. 1988;12:223–226. - PubMed
-
- Reilly RF, Peixoto AJ, Desir GV. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. Clin J Am Soc Nephrol. 2010;5:1893–1903. - PubMed
-
- Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume content (v) and renin-angiotensin (r) vasoconstriction to long-term blood pressure. Am J Hypertens. 2011;24:1164–1180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
